7-10 February 2023 Manchester
| PO-5 | MUTATIONAL PROFILE OF SEVERE TUNISIAN PEOPLE WITH HEMOPHILIA A (PWH A) AND INHIBITORS. | Hejer Elmahmoudi | |
| PO-8 | ARE ONE STAGE AND CHROMOGENIC FVIII:C ASSAYS SUITABLE FOR MEASURING ADYNOVI IN SPIKED PLASMA? | Susan Guy | |
| PO-14 | EXPLORING RED BLOOD CELLS AS A NOVEL TOLEROGENIC APPROACH FOR FACTOR VIII INHIBITORS EMPLOYING IMMUNO-DOMINANT FVIII DERIVED PEPTIDES PRESENTED ON MHC CLASS II | Mariarosaria Miranda | |
| PO-17 | ASSESSMENT OF LIVER FUNCTION IN CROATIAN PATIENTS WITH HAEMOPHILIA B | Josipa Pavic | |
| PO-18 | EFANESOCTOCOG ALFA ACTIVITY ASSESSMENT WITH ONE-STAGE CLOTTING (OSA) AND CHROMOGENIC SUBSTRATE (CSA) FACTOR VIII ASSAYS | Sarah Meadows | |
| PO-21 | DESIGN OF SECOND- AND THIRD-GENERATION FVIII-SPECIFIC CARS DIFFERENTLY IMPACTS PHENOTYPE STABILITY AND RESPONSES TOWARDS FVIII OF TRANSDUCED TREGS | Sarah Scatigna | |
| PO-63 | RETROSPECTIVE STUDY OF THE EFFECTIVENESS AND SAFETY OF THE USE OF RIX-FP IN PATIENTS WITH HAEMOPHILIA B. EXPERIENCE OF FOUR CENTRES IN THE REGION OF CASTILLA Y LEÓN (C&L) | Natalia Carpizo | |
| PO-77 | TEST-RETEST RELIABILITY ANALYSIS OF THE PATIENT REPORTED OUTCOMES BURDENS AND EXPERIENCES (PROBE) STUDY | Elizabeth Clearfield | |
| PO-86 | HRQOL IMPACT AFTER INTRODUCING EMICIZUMAB IN SUB-SAHARAN AFRICA IN THE WFH HUMANITARIAN AID PROGRAM | Elizabeth Clearfield | |
| PO-98 | AN OBSERVATIONAL STUDY TO EVALUATE THE IMPACT AND DISEASE BURDEN IN MODERATE AND SEVERE HEMOPHILIA FROM NURSING AND PATIENT PERSPECTIVE | Itziar Guerra | |
| PO-99 | CORRELATION BETWEEN HEMOPHILIA EARLY ARTHROPATHY DETECTION WITH ULTRASOUND (HEAD-US) SCOREAND HEMOPHILIA JOINT HEALTH SCORE (HJHS) IN PATIENTS WITH HEMOPHILIA | Ons Ghali | |
| PO-106 | EMICIZUMAB PROPHYLAXIS IN SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: OUTCOME AND INDICATIONS. FROM THE UK HAEMOPHILIA CENTRE DOCTORS ORGANISATION | Charles Hay | |
| PO-120 | TAWAM HOSPITAL, AL AIN, UAE EXPERIENCE WITH SWITCHING FROM STANDARD HALF-LIFE RECOMBINANT COAGULATION FACTOR IX TO EXTEND HALF-LIFE RECOMBINANT COAGULATION FACTOR IX, FC FUSION PROTEIN IN PATIENTS WITH SEVERE HEMOPHILIA B | Muhammad Faisal Khanani | |
| PO-122 | PERIOPERATIVE MANAGEMENT WITH EFANESOCTOCOG ALFA IN PATIENTS WITH HEMOPHILIA A IN THE PHASE 3 XTEND-1 STUDY | Lois Roberts-Grant | |
| PO-125 | BARRIERS TO HAEMOPHILIA CARRIERS IDENTIFICATION, SCREENING AND COUNSELLING AN INTERIM ANALYSIS OF THE PROCARRIERS1 STUDY | Evelien Krumb | |
| PO-167 | THIRD INTERIM ANALYSIS OF THE PHASE IV HEM-POWR STUDY EVALUATING THE REAL-WORLD EFFECTIVENESS OF DAMOCTOCOG ALFA PEGOL IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA A | Bethany Lund-Yates | |
| PO-170 | INSIGHTS INTO THE SPANISH MILD AND MODERATE HAEMOPHILIA A COHORT: REAL-WORLD EVIDENCE FROM THE CHESS II STUDY | Itziar Guerra | |
| PO-175 | CLINICAL EXPERIENCE WITH EMICIZUMAB IN SUB-SAHARAN AFRICA: A WFH HUMANITARIAN AID PROGRAM REPORT | Elizabeth Clearfield | |
| PO-176 | NEW PARADIGM IN THE TREATMENT OF HEMOPHILIA B: REAL-LIFE EXPERIENCE WITH RIX-FP | Cristina Sierra | |
| PO-177 | IMPACT ON PAIN AND ACTIVITIES OF DAILY LIVING AFTER SWITCHING TO EMICIZUMAB: INSIGHTS FROM PROBE | Elizabeth Clearfield | |
| PO-192 | BLEEDING CONTROL IMPROVES AFTER SWITCHING TO EMICIZUMAB: REAL WORLD EXPERIENCE FROM 251 CHILDREN IN THE PEDNET REGISTRY | Konrad van der Zwet | |
| PO-194 | SUBCLINICAL SYNOVIAL PROLIFERATION IN PATIENTS WITH SEVERE HAEMOPHILIA A: ADVOCATING ULTRASOUND SCREENING | Flora van Leeuwen | |
| PO-197 | DETERMINATION OF VITAMIN D IN PATIENTS WITH HEMOPHILIA AND DECREASED BONE MINERAL DENSITY | Laura Villarreal-Martinez | |
| PO-198 | ISOKINETIC STRENGTH TESTING IN PATIENTS WITH HEMOPHILIA IN A HEMOPHILIA CLINIC IN MEXICO | Laura Villarreal-Martinez | |
| PO-201 | PAIN MEMORIES IN HAEMOPHILIA PRELIMINARY RESULTS FROM A QUALITATIVE STUDY IN COLLABORATION WITH A PATIENT AND PUBLIC INVOLVEMENT GROUP | Anna Wells | |
| PO-202 | TREATMENT OF BLEEDING EPISODES WITH EFANESOCTOCOG ALFA IN PATIENTS WITH SEVERE HAEMOPHILIA A IN THE PHASE 3 XTEND-1 STUDY | Ellie Hughes | |
| PO-203 | PATIENT EXPERIENCE WITH EFANESOCTOCOG ALFA: RESULTS FROM THE XTEND-1 PHASE 3 CLINICAL TRIAL EXIT INTERVIEWS IN PATIENTS WITH SEVERE HAEMOPHILIA A | Nana Kragh | |
| PO-214 | VEYVONDI IN A PAEDIATRIC POPULATION: A SINGLE-CENTRE EXPERIENCE | sahil bhagat | |
| PO-217 | DIAGNOSIS AND MANAGEMENT OF HEAVY MENSTRUAL BLEEDING IN ADOLESCENTS IN PRIMARY CARE | Anne de Vaan | |
| PO-222 | RECOMBINANT VON WILLEBRAND FACTOR TREATMENT OUTCOMES IN ADULTS WITH VON WILLEBRAND DISEASE IN THE UK: AN INTERIM ANALYSIS | Heena Howitt | |
| PO-224 | STABLE FVIII EXPRESSION IN PATIENTS WITH VON WILLEBRAND DISEASE RECEIVING 1:1 RATIO VWF/FVIII CONCENTRATE | Geoffrey Kuppens | |
| PO-233 | ISTH-BAT AS A DIAGNOSTIC SCREENING TOOL IN WOMEN AND GIRLS WITH HEAVY MENSTRUAL BLEEDING: A SYSTEMATIC REVIEW | Anne de Vaan | |
| PO-245 | RECURRENT VENOUS THROMBOEMBOLIC DISEASE IN A PATIENT WITH SEVERE CONGENITAL FACTOR XIII DEFICIENCY. | Laura Bounaix | |
| PO-249 | LONG-TERM EFFECTIVENESS OF PLASMINOGEN EYE DROPS IN PATIENTS WITH LIGNEOUS CONJUNCTIVITIS: THE ITALIAN EXPERIENCE | Cesare Dalla Porta | |
| PO-260 | GRAY PLATELET SYNDROME WITH NBEAL2 MUTATION ASSOCIATED WITH DYSIMMUNITY | Birgit Frotscher | |
| PO-267 | THROMBOCYTOPENIA DOES NOT ALWAYS MEAN ITP: A SINGLE CENTRE EXPERIENCE | Eman Hassan | |
| PO-271 | IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON INTACT PROTEIN S, APOLIPOPROTEIN CIII AND THE HEMOSTATIC POTENTIAL | Riitta Lassila | |
| PO-281 | INHERITED AUTOSOMAL DOMINANT THROMBOCYTOPENIA: ONE FAMILY DESCRIPTION | Víctor Portela Piñeiro | |
| PO-283 | MANAGEMENT OF BLEEDING DISORDERS OF UNKNOWN CAUSE (BDUC) IN A TERTIARY LONDON HOSPITAL | Sinthiya Punnialingam | |
| PO-293 | CLINICAL APPLICATION OF MULTIGENE PANEL TESTING FOR DIAGNOSIS OF INHERITED COAGULATION DISORDERS | Christine Van Laer | |
| PO-301 | LOCALISATION OF NATIONAL HAEMOPHILIA COMPETENCY FRAMEWORK FOR THE SHEFFIELD HAEMOPHILIA & THROMBOSIS CENTRE SERVICE | Cathy Harrison | |
| PO-303 | IMPROVING PATIENT SAFETY WITH STAFF WELLBEING | Natasha Longsmith | |
| PO-309 | PRESENTATION OF A QUESTIONNAIRE: WOMEN WITH BLEEDING DISORDERS | Malin Svennefalk | |
| PO-310 | WHY AND HOW TO TALK ABOUT SEXUAL HEALTH | Nanda Uitslager | |
| PO-324 | PSYCHOLOGICAL EXPERIENCES OF MOTHERS WITH SEVERE HAEMOPHILIAC CHILDREN IN IRANIAN CULTURE: A PHENOMENOLOGICAL STUDY | Reza Farahani | |
| PO-325 | TEAM HAEM GOES GREEN - A PILOT PROJECT | Claire Forde | |
| PO-328 | Development and useability testing of patient, caregiver and clinician tools to support shared decision making in haemophilia | Shade Olatunde | |
| PO-332 | PERCEPTIONS OF A CAREER IN HAEMOSTASIS & THROMBOSIS - AN INTERNATIONAL PERSPECTIVE | Sinthiya Punnialingam | |
| PO-333 | 360 VIRTUAL REALITY INCREASES TREATMENT ADHERENCE AND EMPOWERMENT IN PEOPLE WITH HEMOPHILIA: PRELIMINARY RESULTS. | Daniel-Anibal Garcia | |
| PO-335 | IMPACT ON AND COMMUNICATION ABOUT SEXUAL FUNCTIONING IN MEN WITH HAEMOPHILIA IN THE NETHERLANDS (HIN-6). | Tessa van Gastel | |
| PO-336 | WOMEN WITH BLEEDING DISORDERS AND THEIR EXPERIENCES IN DAILY LIFE FUNCTIONING IN THE NETHERLANDS. A QUALITATIVE STUDY. | Tessa van Gastel | |
| PO-337 | TRAUMA WORK WITHIN AN INHERITED BLEEDING DISORDERS SERVICE USING EMDR | Sarah Whitaker | |
| PO-338 | EXAMINING TREATMENT PREFERENCES OF PEOPLE WITH HAEMOPHILIA A AND B IN THE UK: A DISCRETE CHOICE EXPERIMENT ENCOMPASSING GENE THERAPY | George Morgan | |
7-10 February 2023 Manchester

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|